Engineers Gate Manager’s Meridian Bioscience Inc VIVO Stock Holding History

Engineers Gate Manager’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-12,774	Closed	-$332K	–	2363
2022 Q1	$332K	Buy	+12,774	New	+$304K	0.01%	1323
2021 Q4	–	Sell	-22,771	Closed	-$438K	–	2375
2021 Q3	$438K	Buy	+22,771	New	+$454K	0.03%	960
2021 Q2	–	Sell	-10,610	Closed	-$279K	–	2157
2021 Q1	$279K	Buy	+10,610	New	+$252K	0.01%	1368
2020 Q4	–	Sell	-33,488	Closed	-$569K	–	2075
2020 Q3	$569K	Buy	+33,488	New	+$651K	0.03%	917
2020 Q2	–	Sell	-16,900	Closed	-$142K	–	2057
2020 Q1	$142K	Sell	16,900 -4,280	-20%	-$36K	0.01%	1349
2019 Q4	$207K	Buy	21,180 +7,873	+59%	+$73.9K	0.01%	1457
2019 Q3	$126K	Sell	13,307 -22,900	-63%	-$241K	0.01%	1278
2019 Q2	$430K	Buy	+36,207	New	+$436K	0.02%	764

Other funds holding VIVO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Impactive Capital New York City, New York $1.38B AUM 1.92% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VLKIM

Van Lanschot Kempen Investment Management Amsterdam, Netherlands $11.4B AUM 16.77% 1-Year Est. Return

Engineers Gate Manager's VIVO Position: Q2 2022 in Review

Engineers Gate Manager sold out of Meridian Bioscience Inc (VIVO) in Q2 2022, closing a stake of 12,774 shares — an estimated $332K sold.

Engineers Gate Manager first reported a position in VIVO in Q2 2019 and held it in 8 quarters. The position peaked at $569K in Q3 2020. 216 funds tracked by Wall St. Rank hold VIVO as of Q2 2022.

Engineers Gate Manager reported no remaining Meridian Bioscience Inc position as of Q2 2022 after selling out during the quarter.
Engineers Gate Manager sold 12,774 Meridian Bioscience Inc shares in Q2 2022, an estimated $332K.
Engineers Gate Manager first reported a position in Meridian Bioscience Inc in Q2 2019 and held it in 8 quarters.
Engineers Gate Manager's Meridian Bioscience Inc position peaked at $569K in Q3 2020.
216 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q2 2022.

Based on Engineers Gate Manager's 13F filing for Q2 2022, filed 15 Aug 2022.